Merkel cell carcinoma of unknown primary origin
- PMID: 22271206
- PMCID: PMC4504007
- DOI: 10.1245/s10434-011-2213-2
Merkel cell carcinoma of unknown primary origin
Abstract
Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine tumor of the skin. MCC from an unknown primary origin (MCCUP) can present a diagnostic and therapeutic challenge. We describe our single-institution experience with the diagnosis and management of MCCUP presenting as metastases to lymph nodes.
Methods: After institutional review board approval, our institutional database spanning the years 1998-2010 was queried for patients with MCCUP. Clinicopathologic variables and outcomes were assessed.
Results: From a database of 321 patients with MCC, 38 (12%) were identified as having nodal MCCUP. Median age was 67 years, and 79% were men. Nodal basins involved at presentation were cervical (58%), axillary/epitrochlear (21%), or inguinal/iliac (21%). CK20 staining was positive in 93% of tumors tested, and all were negative for thyroid transcription factor-1. Twenty-nine patients (76%) underwent complete regional lymph node dissection (LND): 3 had LND alone, ten had LND and adjuvant radiotherapy, and 16 underwent LND followed by chemoradiotherapy. Definitive chemoradiotherapy without surgery was provided to six patients (16%), while radiotherapy alone was provided to three (8%). Recurrence was observed in 34% of patients. Median recurrence-free survival was 35 months. Ten patients (26%) died, five of disease and five of other causes. The median overall survival was 104 months.
Conclusions: Nodal MCCUP is a rare disease affecting primarily elderly white men. Recurrence is observed in approximately one-third of patients, with a 104 month median overall survival after a multimodal treatment approach consisting of surgery along with adjuvant chemotherapy and radiotherapy in the majority of patients.
Figures



Similar articles
-
Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience.Eur Arch Otorhinolaryngol. 2015 Feb;272(2):425-9. doi: 10.1007/s00405-014-2974-x. Epub 2014 Mar 15. Eur Arch Otorhinolaryngol. 2015. PMID: 24633244
-
Merkel cell carcinoma: 30-year experience from a single institution.Ann Surg Oncol. 2013 Apr;20(4):1365-73. doi: 10.1245/s10434-012-2779-3. Epub 2012 Dec 1. Ann Surg Oncol. 2013. PMID: 23208132 Clinical Trial.
-
Merkel Cell Carcinoma of Unknown Primary Origin.Acta Dermatovenerol Croat. 2023 Dec;31(3):153-155. Acta Dermatovenerol Croat. 2023. PMID: 38439727
-
Merkel cell carcinoma of unknown primary: Clinical presentation and outcomes.J Surg Oncol. 2022 Nov;126(6):1080-1086. doi: 10.1002/jso.27010. Epub 2022 Jul 9. J Surg Oncol. 2022. PMID: 35809230 Review.
-
Merkel cell carcinoma: report of 10 cases and review of the literature.J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):755-67. doi: 10.1067/mjd.2000.106505. J Am Acad Dermatol. 2000. PMID: 11050578 Review.
Cited by
-
Clinical significance and epidemiological evolution of epitrochlear lymphadenopathy in pre- and post-highly active antiretroviral therapy era: A systematic review of the literature.Lung India. 2018 Mar-Apr;35(2):150-153. doi: 10.4103/lungindia.lungindia_13_17. Lung India. 2018. PMID: 29487251 Free PMC article.
-
Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles.Cancers (Basel). 2021 Mar 31;13(7):1621. doi: 10.3390/cancers13071621. Cancers (Basel). 2021. PMID: 33807452 Free PMC article.
-
Milestones in the staging, classification, and biology of Merkel cell carcinoma.J Natl Compr Canc Netw. 2014 Sep;12(9):1255-62. doi: 10.6004/jnccn.2014.0123. J Natl Compr Canc Netw. 2014. PMID: 25190694 Free PMC article. Review.
-
Merkel cell carcinoma in Taiwan: A series of 24 cases and literature review.Medicine (Baltimore). 2019 Oct;98(42):e17538. doi: 10.1097/MD.0000000000017538. Medicine (Baltimore). 2019. PMID: 31626116 Free PMC article.
-
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities.Mol Pharm. 2023 Aug 7;20(8):3698-3740. doi: 10.1021/acs.molpharmaceut.2c01080. Epub 2023 Jul 24. Mol Pharm. 2023. PMID: 37486263 Free PMC article. Review.
References
-
- Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89:1–4. - PubMed
-
- Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast Reconstr Surg. 2002;110:1259–1265. - PubMed
-
- Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127:2100–2103. - PubMed
-
- Edge SB, editor. Merkel cell carcinoma. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. pp. 315–323.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources